Lactobacillus Reuteri for H. Pylori Support

Insufficient evidence 1 studies

The available study linked here does not directly investigate Lactobacillus reuteri for H. pylori support. The single study provided examined cross-reactive antibodies between gut commensal bacteria and SARS-CoV-2, finding a relationship between gut microbiome composition and immune responses to COVID-19 vaccination, which is unrelated to H. pylori or Lactobacillus reuteri specifically. Research does exist elsewhere in the broader scientific literature exploring whether Lactobacillus reuteri may help suppress H. pylori colonization or support eradication therapy outcomes, but that evidence cannot be accurately summarized from the studies provided here. Readers interested in this topic are encouraged to seek out the relevant clinical trial and meta-analysis literature directly, as drawing conclusions from the linked material on this particular question would not be an accurate representation of the evidence.

Related studies

Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.

Title Type Year Direction Match
Pre-existing antibodies targeting a linear epitope on SARS-CoV-2 S2 cross-rea... Other 2021 Neutral 90

← Back to Lactobacillus Reuteri

Medical Disclaimer: Noyemi provides information from published research for educational purposes only. This content is not medical advice and does not replace consultation with a qualified healthcare provider. Always consult your doctor before starting, stopping, or changing any supplement regimen, especially if you take medications or have existing health conditions.